Nipro partners with FPT Medica to develop Internet of Medical Things in Vietnam
Nipro, a multinational medical corporation from Japan, has recently partnered with FPT Telecom’s FPT Medicarea on a strategic co-operation agreement to deliver digital medical devices with international standards and affordability.
Through this collaboration, the two companies aim to provide esteemed global smart medical devices and services to the Vietnamese population. This initiative directly addresses the pressing demand for high-quality healthcare and helps alleviate the escalating financial burden associated with healthcare services.
Như Y, general director of Nipro Sales Vietnam Company Ltd, shared that Nipro Sales Vietnam aims to develop chronic healthcare products for Vietnamese people, contributing to improving the quality of lives and reducing healthcare burdens.
The cooperation has seen significant efforts from both companies in launching a smart blood glucose monitoring solution for diabetes, she said.
"Nipro is highly committed to providing high-quality blood glucose monitoring devices with Japanese technology, ensuring accurate and reliable results according to the EN ISO 15197:2015 standard, thereby helping Vietnamese diabetic patients live better,” said Y.
Chronic disease patients such as mellitus diabetes, hypertension, and cardiovascular disease, not only require a medical examination and treatment at a hospital but also prefer being proactive in managing their health and improving their quality of life.
The Internet of Medical Things (IoMT), especially continuous bio-monitoring devices, are connected with health platforms to provide available personal health data and a comprehensive medical picture.
FPT Medicare has obtained full authorisation for the distribution of the Nipro Premier, α Blood Glucose Monitoring System, for all pharmacies and medical device stores throughout Vietnam.
The blood glucose meter is available in more than 1,600 Long Chau pharmacies and the FPT Telecom ecosystem of four million households. This is recognised by both corporations to provide solutions to at least one million diabetes patients, or approximately 20% of the Vietnamese market, in the next three years.
FPT Medicare is striving to leverage technology innovation to provide solutions ahead of an increase in demand from chronic patients.
In December 2023, the FPT Medicare diabetic management platform was introduced, designed to create personalised blood glucose testing schedules by leveraging patient input.
Patient-recorded data will be generated as an insightful blood glucose report and shared with caregivers and physicians once requested. The application offers valuable features empowering patients in efficiently managing their progress and enhancing treatment outcomes.
Director of FPT Medicare Phan Minh Hai said, "FPT Medicare will maximise its distribution network to deliver the product to consumers at an optimal price. We will also provide a smart health-monitoring application for advanced healthcare, so now Vietnamese can start the day with confidence.”
